Freeline Therapeutics (FRLN) Institutional Ownership → Biden replacement revealed? (From Paradigm Press) (Ad) Free FRLN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Freeline Therapeutics (NASDAQ:FRLN)CurrentInstitutional OwnershipPercentage46.26%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$714.19KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$65.95M Get FRLN Insider Trade Alerts Want to know when executives and insiders are buying or selling Freeline Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FRLN Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Freeline Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024PenderFund Capital Management Ltd.60,401$385K0.0%N/A1.391% 1/8/2024Harbor Capital Advisors Inc.20,352$129K0.0%+62.8%0.469% 11/13/2023CHI Advisors LLC86,654$373K0.1%+300.0%1.997% 8/22/2023CHI Advisors LLC21,666$56K0.0%-99.5%0.499% 7/27/2023 Syncona Portfolio Ltd1,466,508$3.78M5.7%-93.3%33.791% 7/11/2023Harbor Capital Advisors Inc.10,709$28K0.0%-90.1%0.247% Get the Latest News and Ratings for FRLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Freeline Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023CHI Advisors LLC4,729,419$2.15M0.6%-1.8%7.279% 2/8/2023Thrivent Financial for Lutherans78,900$37K0.0%N/A0.121% 11/15/2022TFG Asset Management GP Ltd4,000,000$2.80M0.3%+6.4%6.156% 10/28/2022Harbor Capital Advisors Inc.131,957$92K0.1%-10.0%0.203% 5/31/2022 Syncona Portfolio Ltd21,997,620$5.84M5.6%+645.7%61.237% 5/17/2022Eventide Asset Management LLC3,606,192$3.97M0.1%+3.5%10.040% 5/4/2022Prospera Financial Services Inc34,650$39K0.0%+130.3%0.096% 5/3/2022 Values First Advisors Inc.50,149$56K0.0%+117.6%0.140% 4/28/2022Harbor Capital Advisors Inc.144,672$162K0.1%-20.7%0.403% 3/10/2022 Values First Advisors Inc.23,048$46K0.0%N/A0.064% 2/14/2022Novo Holdings A S1,776,613$3.52M0.2%-7.9%4.961% 2/11/2022 Syncona Portfolio Ltd2,950,000$5.84M5.6%N/A8.237% 2/4/2022Harbor Capital Advisors Inc.182,521$360K0.1%N/A0.510% 11/16/2021Wellington Management Group LLP664,836$2.29M0.0%-66.8%1.857% 11/16/2021CHI Advisors LLC1,427,481$4.87M1.4%+3.5%3.987% 11/15/2021Marshall Wace LLP356,126$1.23M0.0%N/A0.995% 11/15/2021Veritable L.P.55,870$191K0.0%N/A0.156% 11/15/2021AXA S.A.566,207$1.93M0.0%+1.9%1.581% 11/12/2021Renaissance Technologies LLC194,500$663K0.0%N/A0.543% 11/12/2021Prospera Financial Services Inc15,047$51K0.0%N/A0.042% 11/1/2021 SG Americas Securities LLC47,390$163K0.0%N/A0.132% 8/16/2021Federated Hermes Inc.12,000$98K0.0%-40.0%0.033% 8/11/2021CHI Advisors LLC1,379,843$11.25M2.6%-0.4%3.850% 5/18/2021Millennium Management LLC66,851$822K0.0%-7.2%0.186% 5/17/2021Ally Bridge Group NY LLC408,726$5.03M1.0%-3.8%1.140% 5/14/2021Sectoral Asset Management Inc654,498$8.05M0.6%-0.5%1.825% 2/16/2021 Ovata Capital Management Ltd14,981$274K0.1%-60.1%0.058% 2/13/2021Polygon Management Ltd.750,000$13.70M0.9%+2.7%2.893% 2/12/2021CHI Advisors LLC1,361,064$24.85M7.0%+2.8%5.251% 2/8/2021FIL Ltd157,968$2.88M0.0%-40.6%0.440% 11/16/2020Hound Partners LLC70,000$1.09M0.1%N/A0.270% 11/13/2020Morgan Stanley13,206$206K0.0%N/A0.051% 11/13/2020AXA S.A.549,154$8.57M0.0%N/A2.119% 11/13/2020 Ovata Capital Management Ltd37,500$585K0.2%N/A0.145% Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here11/12/2020Federated Hermes Inc.20,000$312K0.0%N/A0.077% 11/9/2020 Caas Capital Management LP18,166$284K0.0%N/A0.070% 11/5/2020 California Public Employees Retirement System20,152$315K0.0%N/A0.078% (Data available from 1/1/2016 forward) FRLN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FRLN shares? During the previous two years, the following institutional investors and hedge funds held shares of Freeline Therapeutics shares: Eventide Asset Management LLC ($3.97M), Syncona Portfolio Ltd ($3.78M), TFG Asset Management GP Ltd ($2.80M), PenderFund Capital Management Ltd. ($385K), CHI Advisors LLC ($373K), and Harbor Capital Advisors Inc. ($129K), and Thrivent Financial for Lutherans ($37K).Learn more on FRLN's institutional investors. What percentage of Freeline Therapeutics stock is owned by institutional investors? 46.26% of Freeline Therapeutics stock is owned by institutional investors. Learn more on FRLN's institutional investor holdings. Which institutional investors have been buying Freeline Therapeutics stock? The following institutional investors have purchased Freeline Therapeutics stock in the last 24 months: Syncona Portfolio Ltd ($19.05M), TFG Asset Management GP Ltd ($239.49K), Eventide Asset Management LLC ($120.54K), Thrivent Financial for Lutherans ($78.90K), CHI Advisors LLC ($64.99K), PenderFund Capital Management Ltd. ($60.40K), and Harbor Capital Advisors Inc. ($7.85K). How much institutional buying is happening at Freeline Therapeutics? Institutional investors have bought a total of 19,619,785 shares in the last 24 months. This purchase volume represents approximately $325.82M in transactions. Which Freeline Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Freeline Therapeutics stock in the last 24 months: Syncona Portfolio Ltd ($20.53M), CHI Advisors LLC ($4.79M), and Harbor Capital Advisors Inc. ($111.63K). How much institutional selling is happening at Freeline Therapeutics? Institutional investors have sold a total of 25,435,492 shares in the last 24 months. This volume of shares sold represents approximately $66.10M in transactions. Related Companies: Evaxion Biotech A/S Major Shareholders LianBio Major Shareholders Ocuphire Pharma Major Shareholders Sangamo Therapeutics Major Shareholders FibroGen Major Shareholders Femasys Major Shareholders Aprea Therapeutics Major Shareholders Evogene Major Shareholders Pluri Major Shareholders Nutriband Major Shareholders This page (NASDAQ:FRLN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Freeline Therapeutics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.